Marker Therapeutics, Inc. (MRKR)

1.40 -0.08 (-5.41%) USD  |  NASDAQ  |  Mar 02, 16:00
1.40 0.00 (0.00%) After-Hours: 20:00
More

Marker Therapeutics Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Viridian Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Kiniksa Pharmaceuticals International Plc Upgrade
Neurocrine Biosciences, Inc. Upgrade

Return on Net Operating Assets Related Metrics

Return on Equity Upgrade
Return on Assets Upgrade
Return on Invested Capital Upgrade
Profit Margin (Quarterly) Upgrade
Operating Margin (Quarterly) Upgrade